The global Calcineurin Inhibitor Market is estimated to be valued at US$10.07 billion in 2023 and is expected to exhibit a CAGR of 10.8% over the forecast period (2023-2030), as highlighted in a new report published by Coherent Market Insights.Market Overview:Calcineurin inhibitors are immunosuppressive drugs that are commonly used in the treatment of autoimmune disorders and in organ...
0 Commentarios
0 Acciones
1370 Views
0 Vista previa